首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   878552篇
  免费   72511篇
  国内免费   1871篇
耳鼻咽喉   13139篇
儿科学   25152篇
妇产科学   25388篇
基础医学   126566篇
口腔科学   25910篇
临床医学   76890篇
内科学   167833篇
皮肤病学   17303篇
神经病学   71916篇
特种医学   35999篇
外国民族医学   183篇
外科学   138584篇
综合类   24765篇
现状与发展   2篇
一般理论   269篇
预防医学   68215篇
眼科学   21198篇
药学   65860篇
中国医学   1631篇
肿瘤学   46131篇
  2018年   7615篇
  2015年   8023篇
  2014年   11474篇
  2013年   17332篇
  2012年   23478篇
  2011年   24601篇
  2010年   14337篇
  2009年   13502篇
  2008年   23288篇
  2007年   25411篇
  2006年   25229篇
  2005年   24867篇
  2004年   24368篇
  2003年   23438篇
  2002年   22557篇
  2001年   36378篇
  2000年   37027篇
  1999年   31396篇
  1998年   9432篇
  1997年   8756篇
  1996年   8649篇
  1995年   8141篇
  1994年   7850篇
  1992年   26985篇
  1991年   26425篇
  1990年   25926篇
  1989年   24964篇
  1988年   23536篇
  1987年   23158篇
  1986年   21994篇
  1985年   21326篇
  1984年   16569篇
  1983年   14139篇
  1982年   8966篇
  1981年   8301篇
  1980年   7776篇
  1979年   16902篇
  1978年   12255篇
  1977年   10310篇
  1976年   9448篇
  1975年   10266篇
  1974年   12773篇
  1973年   12256篇
  1972年   11658篇
  1971年   10780篇
  1970年   10332篇
  1969年   10004篇
  1968年   9015篇
  1967年   8319篇
  1966年   7734篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
Cutaneous leiomyomas are rare benign smooth‐muscle tumors. These lesions are distinguished based on their cell of origin and are subclassified as pilar leiomyoma, angioleiomyoma, and genital‐type leiomyoma. Nipple leiomyoma is the least common genital‐type leiomyoma, arising from the dartoic muscle cell of the nipple. Histologic examination of the lesion is necessary for definitive diagnosis, and these uncommon tumors can pose a diagnostic challenge. We describe herein a series of six nipple leiomyomas with a spectrum of histologic appearances.  相似文献   
12.
13.
14.
Purpose: To use polymerase chain reaction (PCR) and Goldmann-Witmer coefficient (GWC) calculation to diagnose infectious uveitis.

Methods: Prospective cross-sectional study.

Results: Twenty-seven of 106 patients had positive PCR and/or GWC results on aqueous humor (AH) sampling and 15 of 27 (55.6%) were HIV-positive. Patients with non-anterior uveitis (NAU) were more likely to be HIV+ (p = 0.005). More than 1 possible pathogen was identified in 9 of 27 patients of whom 7 were HIV+. The final clinical diagnosis was discordant with AH findings in 9 of 27 cases. A positive EBV PCR result was associated with a discordant diagnosis (p = 0.001). All cases of herpetic anterior uveitis (42.9% HIV+) tested PCR-/GWC+ while all cases of herpetic NAU tested PCR+/GWC- (83.3% HIV+). All rubella virus cases were PCR+/GWC+.

Conclusion: PCR is useful to diagnose herpetic NAU in HIV+ patients while GWC is useful to diagnose herpetic anterior uveitis.  相似文献   

15.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
16.
17.
18.
19.
20.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号